Inactive Instrument

Analyst Reco. Dr Pepper Snapple Group Nyse

Equities

US26138E1091

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

JPMorgan Adjusts Keurig Dr Pepper's Price Target to $37 From $34	Apr. 26	MT
Jefferies Adjusts Keurig Dr Pepper's Price Target to $39 From $35	Apr. 26	MT
Wedbush Adjusts Keurig Dr Pepper's Price Target to $37 From $35 After 'Strong' Q1 Beat, Keeps Outperform Rating	Apr. 26	MT
UBS Adjusts Keurig Dr Pepper Price Target to $39 From $36, Maintains Buy Rating	Apr. 26	MT
TD Cowen Adjusts Keurig Dr Pepper's Price Target to $35 From $32	Apr. 26	MT
Bernstein Adjusts Price Target on Keurig Dr Pepper to $39 From $36	Apr. 26	MT
Morgan Stanley Adjusts Price Target on Keurig Dr Pepper to $36 From $34	Apr. 26	MT
Wells Fargo Adjusts Price Target on Keurig Dr Pepper to $39 From $37	Apr. 26	MT
Barclays Raises Keurig Dr Pepper's Price Target to $38 From $36	Apr. 26	MT
Citigroup Adjusts Price Target on Keurig Dr Pepper to $35 From $33	Apr. 26	MT
Evercore ISI Adjusts Keurig Dr Pepper Price Target to $36 From $34, Keeps In Line Rating	Apr. 25	MT
Deutsche Bank Adjusts Keurig Dr Pepper Price Target to $34 From $33, Maintains Hold Rating	Apr. 15	MT
Consumer Edge Adjusts Keurig Dr Pepper's Price Target to $41 From $40	Apr. 15	MT
Barclays Adjusts Price Target on Keurig Dr Pepper to $36 From $32, Maintains Overweight Rating	Apr. 12	MT
Jefferies Cuts Keurig Dr Pepper's Price Target to $35 From $37, Keeps Buy Rating	Mar. 27	MT
Barclays Cuts Price Target on Keurig Dr Pepper to $32 From $34, Keeps Overweight Rating	Mar. 12	MT
ANALYST RECOMMENDATIONS : Block, Estee Lauder, Dell, Netflix, Nvidia...	Mar. 01
Morgan Stanley Cuts Price Target on Keurig Dr Pepper to $34 From $37, Keeps Equalweight Rating	Feb. 26	MT
Wedbush Lowers Keurig Dr Pepper's PT to $35 From $37 After Mixed Q4 2023 Results, Maintains Outperform Rating	Feb. 26	MT
Barclays Cuts Price Target on Keurig Dr Pepper to $34 From $37, Maintains Overweight Rating	Feb. 23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Dr Pepper Snapple Group Nyse

Equities

US26138E1091

Analyst Reco.

Filters